Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 29, 2023

Amneal Pharms Co Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?

AMNEAL PHARMS CO has forty-two approved drugs.

There is one tentative approval on AMNEAL PHARMS CO drugs.

Summary for Amneal Pharms Co

US Patents:	0
Tradenames:	41
Ingredients:	41
NDAs:	42

Drugs and US Patents for Amneal Pharms Co

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	PREGABALIN	pregabalin	CAPSULE;ORAL	209743-004	Jul 19, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms Co	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	208850-003	Oct 16, 2018		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms Co	BUSPIRONE HYDROCHLORIDE	buspirone hydrochloride	TABLET;ORAL	208829-002	May 24, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms Co	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	207482-003	Jun 28, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms Co	TADALAFIL	tadalafil	TABLET;ORAL	209744-003	Mar 26, 2019	AB1	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms Co	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	emtricitabine; tenofovir disoproxil fumarate	TABLET;ORAL	209721-003	Aug 22, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Express Scripts

Moodys

Medtronic

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.